SCHEMBL5508220

SCHEMBL5508220

Cc1ccc2[nH]c(-c3ccccc3O)nc(=O)c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 6/20 0.55
▸ HPGD P15428 3/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ GAA P10253 3/20 0.50
▸ MGAM O43451 2/20 0.50
▸ SI P14410 1/20 0.50
▸ MGAM2 Q2M2H8 1/20 0.50
▸ GUSB P08236 1/20 0.48
▸ FLT3 P36888 1/20 0.47
▸ GSK3A P49840 1/20 0.47
▸ GSK3B P49841 1/20 0.47
▸ CDK5 Q00535 1/20 0.47
▸ CDK5R1 Q15078 1/20 0.47
▸ NPC1 O15118 3/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ POLB P06746 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ PDE5A O76074 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ MAPT P10636 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2372869 0.84 PTGES (0.51) KDM4EHPGDHSD17B10GAAMGAM
SCHEMBL31722934 0.83 KDM4E (0.59) KDM4EHPGDHSD17B10GAAMGAM
SCHEMBL3111166 0.83 KDM4E (0.59) KDM4EHPGDHSD17B10GAAMGAM
SCHEMBL4090569 0.78 GUSB (0.70) KDM4EHPGDHSD17B10GAAGUSB
SCHEMBL296062 0.76 GUSB (0.70) KDM4EHPGDHSD17B10GUSBNPC1
SCHEMBL14141938 0.75 HDAC6 (0.51) KDM4EHPGDHSD17B10GAAGUSB
SCHEMBL7602915 0.73 ALDH1A1 (0.53) KDM4EHPGDHSD17B10GAANPC1
SCHEMBL11245430 0.71 NPC1 (0.50) KDM4EHPGDHSD17B10GAAGUSB
SCHEMBL17717642 0.70 F2 (0.61) KDM4EHPGDHSD17B10GAAMGAM
SCHEMBL7398247 0.70 AMY1A (0.71) KDM4EHPGDHSD17B10GAAMGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828150-A2 PROCESSES FOR PRODUCING 4-AMINOQUINAZOLINES Vertex Pharmaceuticals Incorporated (US) 2007-09-05 — — EP disclosed
WO-2006066044-A2 PROCESSES FOR PRODUCING 4-AMINOQUINAZOLINES VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-06-22 — — WO disclosed
Send feedback